Cargando…
Added value of contrast-enhanced mammography (CEM) in staging of malignant breast lesions—a feasibility study
OBJECTIVES: The aim of this feasibility study was to evaluate the added value of contrast-enhanced mammography (CEM) in preoperative staging of malignant breast lesions, beyond standard assessment with digital mammography and ultrasound, as a base for a future prospective randomized trial. MATERIALS...
Autores principales: | Åhsberg, Kristina, Gardfjell, Anna, Nimeus, Emma, Rasmussen, Rogvi, Behmer, Catharina, Zackrisson, Sophia, Ryden, Lisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243325/ https://www.ncbi.nlm.nih.gov/pubmed/32438917 http://dx.doi.org/10.1186/s12957-020-01865-0 |
Ejemplares similares
-
The PROCEM study protocol: Added value of preoperative contrast-enhanced mammography in staging of malignant breast lesions - a prospective randomized multicenter study
por: Åhsberg, Kristina, et al.
Publicado: (2021) -
Predicting Malignancy of Breast Imaging Findings Using Quantitative Analysis of Contrast-Enhanced Mammography (CEM)
por: Miller, Matthew M., et al.
Publicado: (2023) -
Contrast-enhanced mammography (CEM) versus MRI for breast cancer staging: detection of additional malignant lesions not seen on conventional imaging
por: Taylor, Donna B., et al.
Publicado: (2023) -
Contrast-Enhanced Mammography (CEM) Capability to Distinguish Molecular Breast Cancer Subtypes
por: Luczynska, Elzbieta, et al.
Publicado: (2022) -
Patient satisfaction after unilateral oncoplastic volume displacement surgery for breast cancer, evaluated with the BREAST-Q™
por: Gardfjell, Anna, et al.
Publicado: (2019)